Health Encyclopedia

 

Health Encyclopedia Home



Cervical Cancer Screening Found to Benefit Older Women in New Study

Cervical Cancer Screening Found to Benefit Older Women in New Study

TUESDAY, Jan. 14, 2014 (HealthDay News) -- Cervical cancer screening beyond age 50 saves lives and remains beneficial to women up to age 69, a new British study suggests.

Both the U.S. Centers for Disease Control and Prevention and the U.S. Preventive Services Task Force recommend that cervical cancer screening end at age 65.

In this new study, researchers examined data from all 1,341 women aged 65 to 83 in England and Wales who were diagnosed with cervical cancer between 2007 and 2012, and compared them to women in the same age group who did not have cervical cancer.

The results showed that women who did not undergo cervical cancer screening after age 50 were six times more likely to be diagnosed with cervical cancer than those who had regular screenings between ages 50 to 64 and had no abnormalities. There were 49 cancers in the first group versus eight cancers in the second group per 10,000 women over 20 years, found the study in the journal PLoS Medicine

The rate of cervical cancer was 86 per 10,000 over 20 years among women who were screened regularly between ages 50 to 64 and found to have abnormalities, according to a journal new release.

The findings suggest that cervical cancer screening in older women has a substantial impact in reducing cervical cancer risk, said researchers Peter Sasieni and colleagues from Queen Mary University of London.

"Screening up to age 65 years greatly reduces the risk of cervical cancer in the following decade, but the protection weakens with time and is substantially less 15 years after the last screen. In the light of increasing life expectancy, it would seem inappropriate for countries that currently stop screening between the ages 60 and 69 years to consider reducing the age at which screening ceases," the researchers concluded.

This type of new data from older women can help experts determine whether current guidelines that recommend a halt to cervical cancer screening at age 65 meet all women's needs, Anne Rositch, from the University of Maryland School of Medicine, and colleagues wrote in an accompanying editorial.

Here are the cervical cancer screening guidelines from the U.S. Centers for Disease Control and Prevention:

  • Start getting regular Pap tests at age 21. The Pap test is one of the most reliable and effective cervical cancer screening tests. If your Pap test results are normal, your doctor may tell you that you can wait three years until your next Pap test.

  • If you are 30 years old or older, you may want to have a human papillomavirus (HPV) test along with the Pap test. Both tests can be performed by your doctor at the same time. If your test results are normal, your chance of getting cervical cancer in the next few years is very low. Your doctor may then tell you that you can wait as long as five years for your next screening. But you should still go to the doctor regularly for a checkup.

  • If you are 21 to 65 years old, it is important for you to continue getting a Pap test as directed by your doctor, even if you think you are too old to have a child or are not having sex anymore. If you are older than 65 and have had normal Pap test results for several years, or if you have had your cervix removed as part of a total hysterectomy for non-cancerous conditions, like fibroids, your doctor may tell you that you do not need to have a Pap test anymore.

Here are the cervical cancer screening guidelines from the U.S. Preventive Services Task Force:

  • Women aged 21 to 65 years should have a Pap test every three years. Women aged 30 to 65 who want to lengthen the screening interval can undergo screening with a combination of Pap and HPV testing every five years.

  • Screening is not recommended for women younger than 21, or for women older that 65 "who have had adequate prior screening and are not otherwise at high risk for cervical cancer."

  • Screening is not recommended for women who have had a hysterectomy with removal of the cervix and who do not have a history of a high-grade precancerous lesion or cervical cancer.

  • HPV testing, alone or in combination with a Pap test, should not be used for cervical cancer screening in women younger than 30.

More information

The U.S. National Cancer Institute has more about cervical cancer screening.

SOURCE: PLoS Medicine, news release, Jan. 14, 2014

 
Related Items
Content Type 134
  AIDS-Related Malignancies
Content Type 156
  Cervical Biopsy Podcast
Content Type 167
  Human Papillomavirus (HPV)
  Pap
HealthInk Healthy Tips
  Preventing Cervical Cancer
Drug Reference
  Bleomycin
Cancer Source
  Statistics About Cervical Cancer
  Are You At Risk for Cervical Cancer?
  How Can You Prevent Cervical Cancer?
  What Are the Symptoms of Cervical Cancer?
  How Does Your Doctor Know You Have Cervical Cancer?
  Understanding Your Stage of Cervical Cancer
  Types of Treatment for Cervical Cancer
  What Happens During Surgery for Cervical Cancer?
  Radiation Therapy for Cervical Cancer
  What Happens During Chemotherapy for Cervical Cancer?
  Do What You Can to Ease Side Effects of Treatment for Cervical Cancer
  Early Detection and Prevention Are Keys to Gynecological Health
Cancer FAQs
  Frequently Asked Questions About Cervical Cancer
Quizzes
  Cervical Cancer Quiz
MRAs
  Cervical Cancer Risk Assessment
Daily News Feed
  Too Few Girls Getting HPV Vaccine: CDC
  Cervical Cancer Overlooked in Less-Developed Nations: Study
  Poor Oral Hygiene Tied to Cancer-Linked Virus, Study Finds
  HPV Vaccines May Be Less Effective for Black Women: Study
  Single Dose of HPV Vaccine May Be Enough to Guard Against Cervical Cancer
  HPV Vaccine Rates Lagging in Southern U.S., Study Finds
  Screening for HPV May Be Better Than Pap Test, Study Suggests
  Why Many U.S. Preteens Aren't Getting the HPV Shot
  Many Women Receive Unnecessary Pap Tests, Study Finds
  Many Young Americans Know Little About Cervical Cancer Vaccine
  Precancerous Cells on Cervix Tied to Higher Risk of Disease, Death
  HPV Vaccination Rates Might Rise If More Docs Recommended It
  President's Panel Calls for More Girls, Boys to Get HPV Vaccine
  Partial HPV Vaccine Series May Help Prevent Genital Warts in Girls
  Avastin Shows Mixed Results Against Different Cancers
  More Evidence That HPV Vaccine Might Lower Cervical Cancer Risk
  Study Adds to Evidence That HPV Vaccine Helps Guard Against Cervical Cancer
  FDA Panel Recommends HPV Test As Replacement for Pap Smear
  For Women's Cancers, Where You're Treated Matters
  Cervical Cancer Vaccine Program in England a Success, Researchers Report
  FDA Approves HPV Test as Initial Screen for Cervical Cancer
  U.S. Cervical Cancer Rates Higher Than Thought
  Immune-Based Treatment May Fight Advanced Cervical Cancer
  HIV Patients Less Likely to Get Cancer Treatment: Study
  Most Women Don't Need Regular Pelvic Exams, New Guidelines State
  Cervical Cancer Vaccine Doesn't Boost Clot Risk: Study
  HPV Test Beats Pap Smear in Gauging Cervical Cancer Risk, Study Finds
Adult Diseases and Conditions
  Cervical Cancer
Pediatric Diseases and Conditions
  Pap Test for Adolescents
Test and Procedures
  Cervical Biopsy